Novel Delivery Approaches of Biopharmaceuticals 2025

Surface modification with targeting ligands increases the advantages offered by nanoscale delivery.

Engineered exosomes could reshape therapeutic development by redefining delivery, manufacturing models, and regulatory standards.

Flexible manufacturing processes and facilities support the pipeline of allogeneic cell therapies.

The transformative impact of complex biopharmaceuticals hinges on integrating advanced delivery systems, often accelerated by AI modeling, with robust manufacturing practices and regulatory alignment to ensure stability, safety, and effective patient access.